Neuro-Bio Ltd welcomes Joanna Komorowska as new intern. Joanna is a third-year student of Neuroscience with Psychology at the University of Aberdeen, originally from Poland. She is interested in neurogenerative diseases and how they affect the human body and mind. For...
Neuro-Bio Ltd welcomes Amy-May Pointer as new Laboratory Manager. Amy-May graduated from the University of Nottingham with a Bachelor Honours degree in Microbiology. Her final-year research project focused on Extended-Spectrum Beta-Lactamases (ESBL) Producing...
Neuro-Bio’s paper has been published on “International Journal of Biochemistry and Cell Biology” with the title WHEN A TROPHIC PROCESS TURNS TOXIC: ALZHEIMER’S DISEASE AS AN ABERRANT RECAPITULATION OF A DEVELOPMENTAL MECHANISM. Garcia-Ratés,...
Susan Greenfield, Founder and CEO of Neuro-Bio Ltd, shared her insights on the challenges of developing Alzheimer’s disease treatments, and the fundamental flaw with approaches to date on the “European Biopharmaceutical Review”. To read the full article,...
On Saturday the 25th of June, Neuro-Bio’s CEO Susan Greenfield, will speak at the opening session of the EAN 2022 congress, the biggest meeting in Neurology! Her talk will be “Where Neuroscience meets neurology: blowing, expanding, and losing the...
